Marshall Wace
LNAI

Marshall Wace’s Lunai Bioworks LNAI Stock Holding History

Marshall Wace’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,867
Closed -$89.7K – 3322
2025
Q2 		$89.7K Buy
+3,867
New +$108K ﹤0.01% 2555
2024
Q2 		– Sell
-428
Closed -$90.8K – 2883
2024
Q1 		$90.8K Buy
+428
New +$115K ﹤0.01% 2318
2019
Q2 		– Sell
-108
Closed -$60K – 1753
2019
Q1 		$60K Buy
+108
New +$63.1K ﹤0.01% 1507

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's LNAI Position: Q3 2025 in Review

Marshall Wace sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 3,867 shares — an estimated $89.7K sold.

Marshall Wace first reported a position in LNAI in Q1 2019 and held it in 3 quarters. The position peaked at $90.8K in Q1 2024. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Marshall Wace reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 3,867 Lunai Bioworks shares in Q3 2025, an estimated $89.7K.
  • Marshall Wace first reported a position in Lunai Bioworks in Q1 2019 and held it in 3 quarters.
  • Marshall Wace's Lunai Bioworks position peaked at $90.8K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.